BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Business

  Mazor Robotics To Report Fourth Quarter And Full Year 2013 Financial Results On February 25, 2014

  January 30, 2014

   · 

  1 min read
• Business

  Masimo Corporation To Report Fourth Quarter And Full Year 2013 Financial Results After Market Close On Thursday, February 13

  January 30, 2014

   · 

  3 min read
• Drug Development

  KaloBios Pharmaceuticals, Inc. Pulls Plug On Asthma Drug, Shares Plunge -28.39% At Market Close (January 30, 2014)

  January 30, 2014

   · 

  8 min read
• Deals

  Dicerna Pharmaceuticals Prices Upsized IPO At $15 Per Share

  January 30, 2014

   · 

  3 min read
• Business

  Amgen Has No Intention Of Resuscitating €820 Million Cork Factory Plan

  January 30, 2014

   · 

  1 min read
• BioMidwest

  The New England Journal of Medicine Reviews CareFusion Corporation’s Chloraprep Study In Patient Safety Controversy

  January 30, 2014

   · 

  1 min read
• Business

  Covidien plc Hunts For New CFO

  January 30, 2014

   · 

  1 min read
• Drug Development

  Progenics Pharmaceuticals, Inc. Falls After Two Deaths In Cancer Drug Trial

  January 30, 2014

   · 

  1 min read
• Business

  Eureka Therapeutics Announces License Agreement For Development And Commercialization Of Novel Monoclonal Antibody For Treatment Of Leukemia And Other Cancers

  January 30, 2014

   · 

  2 min read
• Business

  In Stunning Win For Open Science, Johnson & Johnson Will Release Clinical Trial Data To Researchers

  January 30, 2014

   · 

  4 min read